595 related articles for article (PubMed ID: 6488167)
1. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
Kari FW; Kauffman FC; Thurman RG
Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
[TBL] [Abstract][Full Text] [Related]
2. Effect of bile salts on rates of formation, accumulation, and export of mutagenic metabolites from benzo(a)pyrene produced by the perfused rat liver.
Kari FW; Kauffman FC; Thurman RG
Cancer Res; 1985 Apr; 45(4):1621-7. PubMed ID: 3978630
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glucuronidation of benzo(a)pyrene phenols by long-chain fatty acids.
Zhong Z; Kauffman FC; Thurman RG
Cancer Res; 1991 Sep; 51(17):4511-5. PubMed ID: 1908348
[TBL] [Abstract][Full Text] [Related]
4. Benzo(a)pyrene phenol production by perfused rat liver and its inhibition by ethanol.
Reinke LA; McManus P; Kauffman FC; Thurman RG
Cancer Res; 1982 May; 42(5):1681-5. PubMed ID: 6279282
[TBL] [Abstract][Full Text] [Related]
5. Effect of fatty acids on formation, distribution, storage, and release of benzo(a)pyrene phenols and glucuronides in the isolated perfused rat liver.
Zhong Z; Gao W; Kauffman FC; Thurman RG
Cancer Res; 1989 Apr; 49(8):2012-6. PubMed ID: 2702643
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and biliary excretion of benzo[a]pyrene 4,5-oxide in the rat.
Plummer JL; Smith BR; Ball LM; Bend JR
Drug Metab Dispos; 1980; 8(2):68-72. PubMed ID: 6103790
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of uptake and biliary excretion of benzo(alpha)pyrene and mutagenic metabolites in isolated perfused rat liver.
Forti GC; Trieff NM
Teratog Carcinog Mutagen; 1980; 1(3):269-82. PubMed ID: 6119817
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
9. Mutagenic activation of biliary metabolites of benzo(a)pyrene by beta-glucuronidase-positive bacteria in human faeces.
Nanno M; Morotomi M; Takayama H; Kuroshima T; Tanaka R; Mutai M
J Med Microbiol; 1986 Dec; 22(4):351-5. PubMed ID: 3795254
[TBL] [Abstract][Full Text] [Related]
10. The formation of genotoxic metabolites of benzo[a]pyrene by the isolated perfused rat liver, as detected by the bioluminescence test.
Ben-Itzhak J; Levi BZ; Shor R; Lanir A; Bassan HM; Ulitzur S
Mutat Res; 1985 Jun; 147(3):107-12. PubMed ID: 4000152
[TBL] [Abstract][Full Text] [Related]
11. Effect of dietary lipid on benzo(a)pyrene metabolism by perfused rat liver.
Lam TC; Wade AE
Drug Nutr Interact; 1981; 1(1):31-44. PubMed ID: 6926814
[TBL] [Abstract][Full Text] [Related]
12. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
Utesch D; Glatt H; Oesch F
Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
[TBL] [Abstract][Full Text] [Related]
13. Comparative metabolism of benzo(a)pyrene and covalent binding to hepatic DNA in English sole, starry flounder, and rat.
Varanasi U; Nishimoto M; Reichert WL; Le Eberhart BT
Cancer Res; 1986 Aug; 46(8):3817-24. PubMed ID: 3731058
[TBL] [Abstract][Full Text] [Related]
14. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity.
Wiersma DA; Roth RA
J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370
[TBL] [Abstract][Full Text] [Related]
15. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes.
Wood AW; Levin W; Lu AY; Yagi H; Hernandez O; Jerina DM; Conney AH
J Biol Chem; 1976 Aug; 251(16):4882-90. PubMed ID: 821945
[TBL] [Abstract][Full Text] [Related]
17. Role of Kupffer cells in storage and metabolism of benzo(a)pyrene in the liver.
Zhong Z; Goto M; Hijioka T; Oide H; Kauffman FC; Thurman RG
Drug Metab Dispos; 1994; 22(5):680-7. PubMed ID: 7835217
[TBL] [Abstract][Full Text] [Related]
18. Systemic excretion of benzo(a)pyrene in the control and microsomally induced rat: the influence of plasma lipoproteins and albumin as carrier molecules.
Shu HP; Bymun EN
Cancer Res; 1983 Feb; 43(2):485-90. PubMed ID: 6293698
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of 3-benzo[a]pyrenyl glucuronide hydrolysis by calcium activation of microsomal beta-glucuronidase.
Whittaker M; Sokolove PM; Thurman RG; Kauffman FC
Cancer Lett; 1985 Mar; 26(2):145-52. PubMed ID: 3978604
[TBL] [Abstract][Full Text] [Related]
20. Mutagenic activity of biliary metabolites of 6-hydroxymethylbenzo[a]pyrene.
Hughes MF; Kadry AR; Gairola CG; Flesher JW
Mutat Res; 1986 Apr; 173(4):251-6. PubMed ID: 3513004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
